Alliance Global Partners Weighs in on Tilray FY2025 Earnings

Tilray Inc (NASDAQ:TLRY) – Research analysts at Alliance Global Partners cut their FY2025 earnings per share (EPS) estimates for Tilray in a research note issued on Wednesday, April 9th. Alliance Global Partners analyst A. Grey now expects that the company will post earnings of ($1.02) per share for the year, down from their previous forecast of ($0.18). The consensus estimate for Tilray’s current full-year earnings is ($0.20) per share.

TLRY has been the subject of a number of other research reports. Piper Sandler lowered their price objective on shares of Tilray from $2.00 to $1.00 and set a “neutral” rating for the company in a research report on Wednesday, April 9th. Canaccord Genuity Group boosted their target price on shares of Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th.

Tilray Stock Performance

Shares of TLRY stock opened at $0.47 on Monday. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. Tilray has a 12 month low of $0.44 and a 12 month high of $2.52. The company’s fifty day moving average price is $0.70 and its two-hundred day moving average price is $1.15. The firm has a market capitalization of $443.32 million, a P/E ratio of -1.58 and a beta of 1.88.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The firm had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%.

Institutional Trading of Tilray

Several hedge funds have recently modified their holdings of TLRY. Lido Advisors LLC bought a new position in shares of Tilray in the 4th quarter worth $28,000. Verdence Capital Advisors LLC bought a new stake in Tilray during the 4th quarter worth about $29,000. Dudley Capital Management LLC bought a new stake in shares of Tilray during the 4th quarter worth approximately $29,000. Ameritas Advisory Services LLC bought a new stake in shares of Tilray in the 4th quarter valued at about $32,000. Finally, Newman Dignan & Sheerar Inc. grew its holdings in Tilray by 61.9% during the fourth quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company’s stock worth $35,000 after purchasing an additional 10,000 shares during the period. Institutional investors and hedge funds own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.